Omega-3 fatty acids and cardiovascular disease

被引:5
|
作者
Jain, A. P. [1 ]
Aggarwal, K. K.
Zhang, P. -Y. [2 ]
机构
[1] MGIMS, Dept Med, Wardha, India
[2] Xuzhou Cent Hosp, Dept Cardiol, Xuzhou, Jiangsu, Peoples R China
关键词
Cardioceuticals; Omega-3 fatty acids; Cardioprotection; Eicosapentaenoic acid; Docosahexaenoic acid; N-3; FATTY-ACIDS; CORONARY-ARTERY-DISEASE; PRIMARY-PREVENTION; HYPERCHOLESTEROLEMIC PATIENTS; EICOSAPENTAENOIC ACID; SECONDARY-PREVENTION; DIABETES-MELLITUS; SERUM-LIPIDS; RISK-FACTORS; FISH-OIL;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cardioceuticals are nutritional supplements that contain all the essential nutrients including vitamins, minerals, omega-3-fatty acids and other antioxidants like a-lipoic acid and coenzyme Q10 in the right proportion that provide all round protection tothe heart by reducing the most common risks associated with the cardiovascular disease including high low-density lipoprotein cholesterol and triglyceride levels and factors that contribute to coagulation of blood. Omega-3 fatty acids have been shown to significantly reduce the risk for sudden death caused by cardiac arrhythmias and all-cause mortality in patients with known coronary heart disease. Omega-3 fatty acids are also used to treat hyperlipidemia and hypertension. There are no significant drug interactions with omega-3 fatty acids. The American Heart Association recommends consumption of two servings of fish per week for persons with no history of coronary heart disease and at least one serving of fish daily for those with known-coronary heart disease. Approximately 1 g/day of eicosapentaenoic acid plus docosahexaenoic acid is recommended for cardio protection. Higher dosages of omega-3 fatty acids are required to reduce elevated triglyceride levels (2-4 g/day). Modest decreases in blood pressure occur with significantly higher dosages of omega-3 fatty acids.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 50 条
  • [1] Omega-3 fatty acids and cardiovascular disease
    Leaf, A
    Kang, JX
    [J]. NUTRITION AND FITNESS: DIET, GENES, PHYSICAL ACTIVITY AND HEALTH, 2001, 89 : 161 - 172
  • [2] Omega-3 fatty acids and cardiovascular disease
    von Schacky, Clemens
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2007, 10 (02): : 129 - 135
  • [3] Omega-3 fatty acids and cardiovascular disease
    von Schacky, C
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (02): : 131 - 136
  • [4] Omega-3 Fatty Acids and Cardiovascular Disease
    Rogers, Tyler S.
    Seehusen, Dean A.
    [J]. AMERICAN FAMILY PHYSICIAN, 2018, 97 (09) : 562 - 564
  • [5] Omega-3 fatty acids and cardiovascular disease risk
    Müller S.
    [J]. Der Kardiologe, 2018, 12 (4): : 238 - 240
  • [6] Omega-3 fatty acids for cardiovascular disease prevention
    DeFilippis A.P.
    Blaha M.J.
    Jacobson T.A.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2010, 12 (4) : 365 - 380
  • [7] The Utility of Omega-3 Fatty Acids in Cardiovascular Disease
    Saremi, Adonis
    Arora, Rohit
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (05) : 421 - 436
  • [8] Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?
    Bowen K.J.
    Harris W.S.
    Kris-Etherton P.M.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2016, 18 (11)
  • [9] Omega-3 Fatty Acids and Cardiovascular Disease Prevention
    Tomdio, Anna
    Ritchie, Michael
    Miller, Andrew C.
    [J]. AMERICAN FAMILY PHYSICIAN, 2019, 100 (04) : 209 - 210
  • [10] The role of omega-3 fatty acids in cardiovascular disease
    Clemens von Schacky
    [J]. Current Atherosclerosis Reports, 2003, 5 (2) : 139 - 145